Gutiérrez-Cabano C A
Department of Surgical Pathology II, Faculty of Medical Sciences, National University of Rosario, Argentina.
Acta Gastroenterol Latinoam. 1994;24(2):89-97.
The aim of this study was to test the hypothesis that protective effect of subcutaneous acetazolamide, a carbonic anhydrase inhibitor, against ethanol-induced gastric mucosal damage is dependent on indomethacin- or iodoacetamide-sensitive mechanisms. In addition we studied the effects of acetazolamide on gastric motility and the influence of indomethacin and iodoacetamide on this parameter. Indomethacin (30 mg/kg) or iodoacetamide (100 ag/kg) was administered subcutaneously in doses that previously had been demonstrated to inhibit endogenous prostaglandins synthesis and gastric mucosal sulfhydryls respectively. At 30 min after these or control subcutaneous pretreatment, the rats were given subcutaneous acetazolamide or vehicle. Thirty min later 96% ethanol was administered orally and the rats were sacrificed 60 min after ethanol administration. The lesions of the gastric glandular mucosa were measured in length and width and expressed in square millimeters. Gastric motility was recorded by a balloon method. The results showed that neither indomethacin nor iodoacetamide aggravated ethanol-induced gastric mucosal damage. The protective effect of subcutaneous acetazolamide was suppressed by pretreatment with indomethacin but not with that of iodoacetamide. Acetazolamide inhibited gastric motility in a dose-dependent fashion. The inhibited gastric motility induced by acetazolamide was reversed by indomethacin but not by iodoacetamide. A highly significant relationship was found between the inhibitory effect of acetazolamide on the motor activity and the mucosal lesions (r +/- 0.8777, P < 0.01). We conclude that the mechanism mediating subcutaneous acetazolamide protection against 96% ethanolinduced gastric mucosal lesions is dependent on indomethacin- and independent of iodoacetamide sensitive mechanisms.
碳酸酐酶抑制剂乙酰唑胺对乙醇诱导的胃黏膜损伤的保护作用依赖于吲哚美辛或碘乙酰胺敏感的机制。此外,我们研究了乙酰唑胺对胃动力的影响以及吲哚美辛和碘乙酰胺对该参数的影响。皮下注射吲哚美辛(30mg/kg)或碘乙酰胺(100μg/kg),其剂量先前已被证明分别可抑制内源性前列腺素合成和胃黏膜巯基。在这些或对照皮下预处理30分钟后,给大鼠皮下注射乙酰唑胺或赋形剂。30分钟后口服96%乙醇,乙醇给药60分钟后处死大鼠。测量胃腺黏膜损伤的长度和宽度,并以平方毫米表示。通过气囊法记录胃动力。结果表明,吲哚美辛和碘乙酰胺均未加重乙醇诱导的胃黏膜损伤。吲哚美辛预处理可抑制皮下乙酰唑胺的保护作用,而碘乙酰胺预处理则无此作用。乙酰唑胺以剂量依赖性方式抑制胃动力。吲哚美辛可逆转乙酰唑胺诱导的胃动力抑制,而碘乙酰胺则不能。发现乙酰唑胺对运动活性的抑制作用与黏膜损伤之间存在高度显著的相关性(r±0.8777,P<0.01)。我们得出结论,介导皮下乙酰唑胺对96%乙醇诱导的胃黏膜损伤的保护作用的机制依赖于吲哚美辛敏感机制,而独立于碘乙酰胺敏感机制。